Attorney C. J.

Mr. Kishish has been aggressively practicing law since 1992. He is directly responsible for recovering over $171,000,000 for his clients from a variety of matters, including Personal Injury/Mass Tort type cases and Class Action settlements. We provide absolutely free confidential consultations, and never charge any fees or costs unless you first recover.

The Kishish Law Group, LLC

The Kishish Law Group is based in Minnesota. When hiring a law firm, it is important to perform research and take your time. Ask a lot of questions and determine who you feel most comfortable trusting. Remember, any law firm can claim that it can successfully handle personal injury cases. Make certain that is the situation.

Areas Of Practice

Exclusively representing Plaintiffs in the following types of cases:


  • Mass Tort Litigation

    If you think you or a loved one has been injured by a pharmaceutical drug or medical device, we are interested in what you have to say. Your story is important to us. Our clients do not need to stand alone. We guide them through their case and help them understand the legal issues. We are available to listen to your concerns as well as answer your questions as you decide your next step.

    To speak with us for a free case evaluation, please call 1 (888) 402-5552 or use the contact form.

  • Personal Injury

    We are pleased to offer our experience and resources to you and to help you recover the maximum monetary compensation for your pain and suffering. Serious injuries sustained in a car, truck, motorcycle, or train accident, such as a catastrophic burn, spinal cord injury, or traumatic brain injury can be permanently and significantly life changing.

    We know that a personal injury or medical claim can be daunting. We take great pride in helping our clients. It is our goal to relieve our clients of the many challenges and frustrations that pose a threat to their legal right to compensation.

    The most important aspect of our firm is our commitment to our clients. We understand the serious nature of the injuries that our clients have sustained and we are 100% committed to helping our clients through the difficult times they face. Call today for a free consultation with an experienced personal injury lawyer at 1 (888) 402-5552 (Toll Free).

Featured Lawsuits

We provide absolutely free confidential consultations, and never charge any fees or costs unless you first recover.

Free Case Evaluation

Speak with a Lawyer

Attorney C. J. Kishish II and Legal Assistant

The Kishish Law Group is committed to seeking justice for you and your loved ones. We deal with all your legal concerns, so you can focus on your life.

Free Case Evaluation

We at Kishish Law are committed to our clients. We understand the serious nature of the injuries that our clients have sustained and we are steadfast in helping them move on with their lives. We fight to achieve the best possible result.

Recent Articles


The Week in Numbers, July 21st Edition

The Week in Numbers, July 21st Edition

July 21, 2017 - The Week in Numbers » A weekly update on interesting numbers in product liability, class action and mass tort news from July 14–July 20. Published Fridays. 33% The percent of increased risk for ovarian cancer claimed in a class action suit against Johnson & Johnson’s talc products, dismissed Monday. Johnson & Johnson and their talc supplier Imerys had been criticized for not disclosing the risk of ovarian cancer associated with their talc products, including Baby Powder and Shower to Shower....

The Week in Numbers, July 14th Edition

The Week in Numbers, July 14th Edition

July 14, 2017 - The Week in Numbers » A weekly update on interesting numbers in product liability, class action and mass tort news from July 7–July 13. Published Fridays. $3.3 billion The sales of Bristol-Myers Squibb and Pfizer’s Eliquis, a significant portion of the $10 billion anticoagulant market. This week, plaintiffs related to a man who died after taking Eliquis accused Bristol-Myers and Pfizer of failing to adequately test the drug and not advertising that the drug had no known antidote. The claims...

IVC Filter Use Drops, but Still Too High, Says Doctor

IVC Filter Use Drops, but Still Too High, Says Doctor

July 13, 2017 - IVC Filter » In new research published in JAMA Internal Medicine, Dr. Satyajit Reddy and colleagues show that following a 2010 FDA advisory concerning inferior vena cava (IVC) filters, implantation of IVC filters decreased in the United States. In 2010, research by Nicholson et al. revealed that Bard Recovery and Bard G2 IVC filters had a high risk of cracking and breaking off into the body, causing life-threatening risks. After the FDA received 921 adverse event reports of...